title: Chest pain resulting from histoplasmosis pericarditis: a brief report and review of the literature.
abstract: Histoplasmosis is an endemic disease in many regions of the United States. Physicians must be aware of the clinical syndromes and take advantage of epidemiologic clues when diagnosing histoplasmosis pericarditis. Clinicians must also be familiar with the uses and limitations of a battery of serologic and mycologic tests. Finally, further clinical trials are needed to study the role of antifungal therapy in the treatment of histoplasmosis pericarditis.
authors.affiliation: UT Southwestern Medical Center at Dallas, Dallas, Texas 75390-9047, USA.
authors.forename: Jessica J
authors.initials: JJ
authors.lastname: Wang
authors.forename: Sharon C
authors.initials: SC
authors.lastname: Reimold
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D002637:Chest Pain / Q000209:etiology* / Q000503:physiopathology; D006658:Histoplasma; D006660:Histoplasmosis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D010493:Pericarditis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D010496:Pericardium / Q000382:microbiology / Q000473:pathology; D015995:Prevalence; D014481:United States / Q000453:epidemiology
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole